Yahoo
NasdaqGM - Nasdaq Real Time Price USD

CorMedix Inc. (CRMD)

5.32 +0.09 (+1.72%)
At close: November 6 at 4:00:01 PM EST
5.35 +0.03 (+0.56%)
After hours: November 6 at 7:54:28 PM EST
Trade CRMD on Coinbase

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Joseph Todisco MBA
CEO & Chairman of the Board of Directors 1.61M -- 1976
Ms. Elizabeth Masson-Hurlburt B.A.
Executive VP and Chief Operating & Commercial Officer 959.37k -- 1979
Ms. Kaufman Beth Zelnick Esq.
EVP, Chief Legal and Compliance Officer & Corporate Secretary 981.59k -- 1961
Ms. Susan Blum
EVP & Chief Financial Officer -- -- 1973
Ms. Beth Steinbrenner
SVP & Chief Human Resource Officer -- -- --
Donna Ucci
Senior VP & Head of Global Quality -- -- --
Dr. Tushar Mukherjee
Senior VP & Head of Technical Operations -- -- --
Dr. Peter Sullivan BCOP, Pharm.D.
Senior Vice President of Market Access -- -- --
Mr. Jared L. Crandon Pharm.D.
Executive Director of Clinical Portfolio Management -- -- --

CorMedix Inc.

389 Interpace Pkwy
Suite 450
Parsippany, NJ 07054
United States
908 517 9500 https://cormedix.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
191

Description

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.

Corporate Governance

CorMedix Inc.’s ISS Governance QualityScore as of November 1, 2026 is 6. The pillar scores are Audit: 9; Board: 7; Shareholder Rights: 7; Compensation: 6.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 12, 2026 at 1:30 PM UTC

CorMedix Inc. Earnings Date

Recent Events

November 2, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 19, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 13, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 7, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 2, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 1, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 25, 2026 at 12:00 AM UTC

S-8 POS: Offering Registrations

June 24, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 8, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 14, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: